THE BEHAVIORAL TOXICITY OF REVERSIBLE INHIBITORS OF MONOAMINE-OXIDASE-A - LABORATORY AND CLINICAL INVESTIGATIONS

Citation
Db. Fairweather et I. Hindmarch, THE BEHAVIORAL TOXICITY OF REVERSIBLE INHIBITORS OF MONOAMINE-OXIDASE-A - LABORATORY AND CLINICAL INVESTIGATIONS, Journal of clinical psychopharmacology, 15(4), 1995, pp. 68-75
Citations number
43
Categorie Soggetti
Pharmacology & Pharmacy",Psychiatry,Neurosciences
ISSN journal
02710749
Volume
15
Issue
4
Year of publication
1995
Supplement
2
Pages
68 - 75
Database
ISI
SICI code
0271-0749(1995)15:4<68:TBTORI>2.0.ZU;2-F
Abstract
Measuring the effect of an antidepressant on performance tests of psyc homotor ability and cognitive processing is important in order to obta in an objective assessment of its psychotropic activity. It is also es sential to identify potential interference with everyday activities su ch as driving, operating machinery, and performing domestic tasks and to assess the extent to which central nervous system side effects may compound the cognitive and psychomotor impairment resulting from depre ssive illness. Older compounds such as amitriptyline impair performanc e on these tests, whereas the newer antidepressant moclobemide appears to have no effect. What remains to be clarified is whether these test s are predictive of the behavioral side effects that may occur in depr essed patients.